Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (853)	3/26/1998 8:03:00 PM
From: David Cathcart	Respond to of 1826

Thanks Rick, Until last week, I didn't care much for charts. However that one's a work of art. I just copied it to be my computer's Wallpaper. Let's hope we have an even better looking one tomorrow. Go MOGN! David

To: scaram(o)uche who wrote (853)	3/26/1998 8:28:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 1826

Rick: I can just see this chart at the advisory committee meeting: "So let's see if we have this right, Mr Harmon. When the chart's red, that means it's bearish, correct?" "Correct." "That means the stock is going to go down and you should sell, right?" "Yup." "But wouldn't you have actually done better in practice if you had _bought_ when the chart was red?" "Well in _this_ case that may be true, but that's because MOGN was undervalued and, as you've seen, MGI-114 works great." "You're telling us that the people who use this chart weren't properly blinded?" "I guess not." "Well we're obviously going to approve the drug, but your supplementary application for this chart stuff is going to have to go back to Phase I. It _is_ a very pretty chart though." Peter